Skip to content
777 Sourcing.

Capability

immunotherapy research and development

Suppliers
1
States & provinces
1
Countries
1

1 immunotherapy research and development supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

AGENUS INC.

LEXINGTON, MA

Agenus is a clinical-stage immunotherapy company focused on activating the immune system to fight cancer. Its lead program is botensilimab (BOT) plus balstilimab (BAL), a next-generation CTLA-4 plus PD-1 antibody combination designed to convert immune-cold tumors into immune-active ones. The company reports 12 clinical-stage antibody programs and more than 30 years of immunotherapy innovation.

antibody therapeuticsclinical trialsinvestigator-sponsored research

Compiled from public sources

Related capabilities

Other processes offered by the shops that list immunotherapy research and development.

Browse all capabilities